Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Lifeline Co's Other Operating Expense for the
three
months ended in Mar. 2026 was 円5,875 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円23,274 Mil.
Japan Lifeline Co's quarterly Other Operating Expense
increased
from Sep. 2025 (円5,440 Mil) to Dec. 2025 (円5,750 Mil) and
increased
from Dec. 2025 (円5,750 Mil) to Mar. 2026 (円5,875 Mil).
Japan Lifeline Co's annual Other Operating Expense
increased
from Mar. 2024 (円16,027 Mil) to Mar. 2025 (円17,049 Mil) and
increased
from Mar. 2025 (円17,049 Mil) to Mar. 2026 (円17,277 Mil).
Japan Lifeline Co Other Operating Expense Related Terms
Japan Lifeline Co Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Japan Lifeline Co's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円23,274 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of 円23,274 Mil mean?
Japan Lifeline Co (TSE:7575) has a Other Operating Expense of 円23,274 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Japan Lifeline Co and its competitors.
Is Japan Lifeline Co's Other Operating Expense too high?
Japan Lifeline Co's current Other Operating Expense is 円23,274 Mil. Overall, Japan Lifeline Co has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Japan Lifeline Co's Other Operating Expense compare to ABT and SYK?
Japan Lifeline Co's Other Operating Expense of 円23,274 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Japan Lifeline Co and its competitors. Japan Lifeline Co's current Other Operating Expense is 円23,274 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Lifeline Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Lifeline Co (TSE:7575) is currently considered Fairly Valued. The stock's GF Value™ is 円1,547.28, compared to a current price of 円1,530.00 — trading 1.1% below its estimated fair value. The current Other Operating Expense is 円23,274 Mil. Japan Lifeline Co's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Japan Lifeline Co (TSE:7575), the current Other Operating Expense is 円23,274 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Lifeline Co (TSE:7575) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be undervalued.
The current stock price of 円1,530.00 is trading 1.1% below its estimated GF Value™ of 円1,547.28.
GuruFocus considers Japan Lifeline Co to be Fairly Valued.
Key valuation signals for TSE:7575:
Other Operating Expense: 円23,274 Mil
GF Value™: 円1,547.28 vs. price of 円1,530.00 (1.1% below fair value)
No single metric tells the full story. See the TSE:7575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
93GF Score
Get the complete analysis for TSE:7575
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7575 has been successfully added to your 
